Serological biomarkers for development of Rheumatoid arthritis related interstitial lung disease

Adam Young, Elena Nikiphorou, E. Chan, V. Saravanan, J. Dawson, N. Sathi, F. Woodhead, M. Nisar, S. Arthanari, Y. Ahmad, C. Kelly

Research output: Contribution to journalMeeting abstract

Abstract

Background/Purpose: Interstitial Lung Disease (ILD) is the commonest manifestation of lung disease in Rheumatoid Arthritis (RA) and the only complication reported to be increasing in prevalence, accounting for 6% of all RA deaths. High resolution computed tomography (HRCT) confirmed 25% of RA patients had radiological evidence of ILD. This study examines predictive factors for RA-ILD in a large multi centre UK cohort.
Original languageEnglish
JournalArthritis and Rheumatism
Publication statusPublished - 30 Oct 2013
Event2013 ACR/ARHP Annual Meeting - San Diego, United States
Duration: 25 Oct 201330 Oct 2013

Fingerprint

Dive into the research topics of 'Serological biomarkers for development of Rheumatoid arthritis related interstitial lung disease'. Together they form a unique fingerprint.

Cite this